Cargando…
Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders
BACKGROUNDS: Little clinical data is available on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with muscular disorders (MDs). The immunogenicity of SARS-CoV-2 vaccines against MDs, in particular, remains unknown. Thus, this study aimed to confirm the immunogenicity and sa...
Autores principales: | Kasai, Ryousuke, Funato, Michinori, Maruta, Kanako, Yasuda, Kunihiko, Minatsu, Hiroshi, Ito, Junji, Takahashi, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941142/ https://www.ncbi.nlm.nih.gov/pubmed/36825020 http://dx.doi.org/10.3389/fimmu.2023.1103196 |
Ejemplares similares
-
Efficacy of interferential current transcutaneous electrical sensory
stimulation through the neck skin for treating dysphagia in children with
disabilities: A case series
por: Funato, Michinori, et al.
Publicado: (2023) -
Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens
por: Day, Suzanne, et al.
Publicado: (2022) -
Mucosal and cellular immune responses elicited by nasal and intramuscular inoculation with ASFV candidate immunogens
por: Xu, Lulu, et al.
Publicado: (2023) -
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA
por: Stolovich-Rain, Miri, et al.
Publicado: (2023) -
Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)